Quidel | QDEL - 税前利润

金融业

USD

USD 5.77B

现金及等价物

USD 169.8M

USD 448.8M

USD 1.45B

USD 966.1M

USD 2.84B

USD -37.3M

USD 153.3M

6.6K

EPS每股收益

USD 0.46

股本和储备

USD 1.92B

USD 274.8M

债务利息支出

USD 5.68B

USD -10.78

USD 2.47B

USD 1.02B

USD -733M

USD 760.9M

USD -37.3M

普通股股本

USD 67.9M

2.03

USD -756.9M

USD 724M

销售和管理费用

USD 194.4M

USD 577.6M

贸易债权人

USD 279.4M

应收帐款人

USD 417M

	税前利润	更改		日
Abbott	USD 2.36B		178M	2025-12
Agilent	USD 442M		1000K	2025-09
Avanos Medical	USD -1.2M		74.7M	2025-09
Becton, Dickinson and Co.	USD 393M		117M	2025-12
Bruker	USD -72.6M		73.1M	2025-09
Cerus	USD -20.76M		17.9M	2024-12
Charles River Laboratories	USD 170.03M		98.62M	2025-09
Danaher	USD 1.08B		421M	2025-09
Exact Sciences	USD -17.76M		17.7M	2025-09
Haemonetics	USD 59.97M		8.69M	2025-12
Hologic	USD 229.7M		2.3M	2025-12
Illumina	USD 220M		86M	2025-09
IQVIA Holdings	USD 6.16B		5.84B	2025-09
Merit Medical Systems	USD 73.18M		29.8M	2025-09
Mettler Toledo International	USD 269.24M		20.58M	2025-09
Myriad Genetics	USD 4.6M		3.4M	2025-12
Neogen	USD 28M		15.81M	2025-09
OraSure Technologies	USD -18.43M		5.14M	2025-12
Pacific Biosciences Of California	USD -40.17M		2.55M	2025-12
Quidel	USD -756.9M		527.3M	2025-09
Revvity	USD 55.68M		115.97M	2025-09
STAAR Surgical	USD 18.79M		44.7M	2025-09
Thermo Fisher Scientific	USD 2.12B		295M	2025-12
Waters	USD 170.12M		7.57M	2025-09